Abstract
ObjectiveSLE is more prevalent in populations of African (AA) than European ancestry (EA) and leucopenia is common. A homozygous variant inACKR1(rs2814778-CC) is associated with lower white cell counts; the variant is common in AA but not EA populations. We hypothesised that in SLE: (1) leucopenia is more frequent in patients of AA than EA, and (2) theACKR1-CC genotype accounts for the higher frequency of leucopenia in AA patients.MethodsWe performed a retrospective cohort study in patients with SLE at a tertiary care system. Ancestry was defined by genetic principal components. We compared the rate of leucopenia, thrombocytopenia and anaemia between (a) EA and AA patients, and (b)ACKR1-CT/TT and CC genotype in AA patients.ResultsThe cohort included 574 patients of EA and 190 of AA;ACKR1-CC genotype was common in AA (70%) but not EA (0%) patients. Rates of leucopenia for ancestry and genotype were AA 60.0% vs EA 36.8 % (p=1.9E-08); CC 67.7% vs CT/TT 42.1% (p=9.8E-04). The rate of leucopenia did not differ by ancestry comparing EA patients versus AA with CT/TT genotype (p=0.59). Thrombocytopenia (22.2% vs 13.2%, p=0.004) and anaemia (88.4% vs 66.2%, p=3.7E-09) were more frequent in AA patients but were not associated withACKR1genotype (p=0.82 and p=0.84, respectively).ConclusionsSLE of AA had higher rates of anaemia, leucopenia, and thrombocytopenia than those of EA; only the difference in leucopenia was explained byACKR1-CC genotype. This genotype could affect clinical practice.
Funder
National Center for Advancing Translational Sciences
National Institute of General Medical Sciences
Lupus Research Alliance
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Subject
Rheumatology,General Medicine